from
ISI Research Reports20 page (5665 word) report
published Mar 06, 2008
Price
$675.00 available for immediate download
Report Overview
Search Inside
About
ISI Research Reports
In 2006, India ranked 12th in the global pharmaceutical market in dollar terms with a market share of 1.27% globally. It was estimated that India's pharmaceutical industry is worth USD 8.8 billion in 2005. Indian companies continue to dominate the generic market with a total market share of 70% in 2006. Meanwhile, India's pharmaceutical industry accounted for approximately 21% of the global DMFs. India has 75 US FDA approved plants, the highest number of US FDA approved plants outside US. Apart from the relatively low development cost and skilled manpower, the availability of raw materials at competitive prices makes India a preferred manufacturing hub for pharmaceutical giants. Another obvious reason is its IT prowess. As pharmacy research becoming more and more IT oriented, India is in a position to leverage on its strong IT base. India is also emerging as an important destination for global pharmaceutical companies, which are increasingly considering outsourcing and off shoring their drug discovery, research and development, and clinical research.
|
| Source: | ISI Analytics
|
| Document ID: | INP1
|
| Country: | India
|
| Industry: | Pharmaceutical
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
Insight and analysis from ISI own on-the-ground analysts in the emerging markets, who combine original research with data from our proprietary industry databases.
